AYTU vs EIX · rev $66.4M vs P/E 7.3, rev $17.60B
Aytu BioScience Inc (AYTU) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. Revenue was up 1.8% from 2024-06-30 to 2025-06-30. AYTU currently screens at market cap $24.1M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
AYTU currently screens at market cap $24.1M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the AYTU and EIX stock pages for the full models.
Not investment advice.